Suppliers / Taro Pharmaceuticals

Taro Pharmaceuticals

Israel 2 duplicate records merged Updated 9 July 2026

Taro Pharmaceuticals is a finished-dose manufacturer based in Israel. It appears in 1,224 regulatory filings across 17 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada, NMRC (NA) and MPA (SE). Its GMP standing is certified by NAFDAC (NG). Its most recent recorded inspection, by US FDA, closed on 8 December 2022 as NAI.

0
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
1,224
filings across 17 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
7 of 7 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 8 December 2022 NAI US FDA
  • 11 July 2019 VAI US FDA
  • 5 February 2017 VAI US FDA
  • 21 May 2015 VAI US FDA
  • 6 December 2012 NAI US FDA
  • 28 May 2010 VAI US FDA
  • 10 September 2009 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Israel, Israel 3002808385
Paonta Sahib, Nigeria Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
Health Canada 666 None
NMRC (NA) 159 None
MPA (SE) 110 None
US FDA 77 None
ARCSA (EC) 60 None
DKMA (DK) 41 None
NAFDAC (NG) None 3

Questions about Taro Pharmaceuticals

Does Taro Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Taro Pharmaceuticals. It does have 1,224 filings with 17 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Taro Pharmaceuticals FDA-registered?
One site operated by Taro Pharmaceuticals carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Taro Pharmaceuticals's last inspection go?
The most recent inspection on record closed on 8 December 2022 as NAI (No Action Indicated: nothing objectionable was found). 7 inspections are on file.
Where does Taro Pharmaceuticals manufacture?
2 registered sites are on record, in Israel and Nigeria (Israel and Paonta Sahib). Every site is listed on this page with the register it came from.
Which regulators recognise Taro Pharmaceuticals's GMP?
Current GMP certificates are on record from NAFDAC (NG). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Taro Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 8 December 2022.

Comparable suppliers

Abic also in Israel Dexcel Pharma also in Israel Padagis Israel also in Israel Rafa Laboratories also in Israel Finetech Pharmaceutical also in Israel

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates